Cargando…
Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions
Autores principales: | Heymans, Stephane, Dawson, Dana, Fuster, Valentin, Metra, Marco, Tocchetti, Carlo Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the American College of Cardiology Foundation. Published by Elsevier.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512040/ https://www.ncbi.nlm.nih.gov/pubmed/36175054 http://dx.doi.org/10.1016/j.jacc.2022.08.003 |
Ejemplares similares
-
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022) -
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week
por: Kawakami, Rika, et al.
Publicado: (2021) -
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19
por: Bikdeli, Behnood, et al.
Publicado: (2021) -
Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week
por: Farkouh, Michael E., et al.
Publicado: (2022) -
Pathophysiology of ocular toxoplasmosis: Facts and open questions
por: Greigert, Valentin, et al.
Publicado: (2020)